Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.82% | -140.52% | -38.03% | -67.80% | -26.34% |
| Total Depreciation and Amortization | 36.05% | -5.80% | 5.61% | -7.79% | -8.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.21% | 64.39% | 3.76% | -38.78% | 8.75% |
| Change in Net Operating Assets | 266.98% | -49.61% | -4.89% | 245.81% | -24.13% |
| Cash from Operations | 4.16% | -128.25% | -48.31% | -47.41% | -39.43% |
| Capital Expenditure | 93.91% | 58.68% | -1,122.18% | -162.12% | -1.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,065.94% | -50.90% | 184.71% | 287.34% | -111.45% |
| Cash from Investing | 1,288.35% | -50.74% | 181.68% | 300.20% | -120.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 647.40% | -47.67% | -- | -99.73% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -848.44% | 10,700.19% | -- | -99.73% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.14% | -13.15% | 122.70% | -105.21% | -335.37% |